We are monitoring the impact of COVID-19 on Europe OTC Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 463
Share on
Share on

Europe Over the Counter Drugs Market Research Report - Segmented By Product Type, Formulation Type, Distribution Channels & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 463
Pages: 145

EU OTC Drugs Market Size (2020 to 2025)

The size of the European Over the counter drugs market was estimated at USD 52.41 Million in 2020. It is further projected to reach USD 77.30 Million by 2025, growing at a CAGR of 8.08% between 2020 to 2025.

Over the counter (OTC) drugs are the safe and effective drugs used for common ailments and can be bought at pharmacies and local stores, over the counter, without a doctor’s prescription. Acetaminophen, aspirin, and ibuprofen are the most common OTC drugs. Easy accessibility, low cost, convenience, customer-empowering qualities are benefiting the OTC drugs market in Europe.

In Europe, the public started showing a pro-active approach towards the ailments and resorting to lower-priced alternatives due to rising healthcare costs. The cultural shift in public towards self-reliance is helping the pharma firms gain major acquisitions. These are some of the drivers that are fueling the market growth. The market growth is hindered majorly due to the issue of drug substance abuse.

This research report on the European OTC Drugs Market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Analgesics
  • Cough, Cold, and Flu Products
  • Vitamins and Minerals
  • Dermatological Products
  • Gastrointestinal Products
  • Ophthalmic Products
  • Sleep Aid Products
  • Weight Loss/Diet Products
  • Others

By Formulation Type:

  • Tablets
  • Liquids
  • Ointments
  • Spray                             

By Distribution Channels: 

  • Pharmacies
  • Supermarkets/Hypermarkets
  • Convenience store
  • Others (online drug store)                             

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Annual growth for developed nations is decreasing, while the growth is stable for developing nations like Poland. Ukraine and Bulgaria are the most rapidly developing markets. The governments in the EU are attempting to shift the costs to customers and save doctors’ and pharmacists’ resource costs.

Key players operating in the European Over The Counter Drugs Market profiled in this report are GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda. They are the top companies that contribute to the North American OTC drugs market. Loss of patent protection is leading the companies to switch to OTC.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Analgesics

                                5.1.2 Cough, Cold and Flu Products         

                                5.1.3 Vitamins and Minerals       

                                5.1.4 Dermatological Products   

                                5.1.5 Gastrointestinal Products 

                                5.1.6 Ophthalmic Products          

                                5.1.7 Sleep Aid Products              

                                5.1.8 Weight Loss/Diet Products               

                                5.1.9 Others      

                5.2 By Formulation Type                              

                                5.2.1 Tablets      

                                5.2.2 Liquids      

                                5.2.3 Ointments               

                                5.2.4 Sprays       

                5.3 Distribution Channels                             

                                5.3.1 Pharmacies             

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drug Stores)            

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 GlaxoSmithKline                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Johnson and Johnson                            

                8.3 Novartis                       

                8.4 Bayer                            

                8.5 Pfizer                            

                8.6 Boehringer Ingelheim                            

                8.7 Sanofi                           

                8.8 Takeda                         

                8.9 PGT Healthcare                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Over the Counter (OTC) Drugs Market, By Region, From 2020 to 2025 (USD Million)
  2. Europe Over the Counter (OTC) Drugs Market, By Product Type, From 2020 to 2025 (USD Million)
  3. Europe Analgesics Market, By Region, From 2020 to 2025 (USD Million)
  4. Europe Cough Market, By Region, From 2020 to 2025 (USD Million)
  5. Europe Cold and Flu Products Market, By Region, From 2020 to 2025 (USD Million)
  6. Europe Dermatological Products Market, By Region, From 2020 to 2025 (USD Million)
  7. Europe Gastrointestinal Products Market, By Region, From 2020 to 2025 (USD Million)
  8. Europe Vitamins Market, By Region, From 2020 to 2025 (USD Million)
  9. Europe Minerals Market, By Region, From 2020 to 2025 (USD Million)
  10. Europe Weight Loss Products Market, By Region, From 2020 to 2025 (USD Million)
  11. Europe Sleep Aids Market, By Region, From 2020 to 2025 (USD Million)
  12. Europe Ophthalmic Products Market, By Region, From 2020 to 2025 (USD Million)
  13. Europe Smoking Cession Aids Market, By Region, From 2020 to 2025 (USD Million)
  14. Europe Other Products Market, By Region, From 2020 to 2025 (USD Million)
  15. U.K Over the Counter (OTC) Drugs Market, By Product Type, From 2020 to 2025 (USD Million)
  16. Spain Over the Counter (OTC) Drugs Market, By Product Type, From 2020 to 2025 (USD Million)
  17. Germany Over the Counter (OTC) Drugs Market, By Product Type, From 2020 to 2025 (USD Million)
  18. Italy Over the Counter (OTC) Drugs Market, By Product Type, From 2020 to 2025 (USD Million)
  19. France Over the Counter (OTC) Drugs Market, By Product Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample